Moira Ringo
Director, Consulting
Moira comes to Clarivate with over 20 years of experience in healthcare industry and consulting, and focusses primarily on commercial strategy and market access. Moira began her career in GSK Research and Development after witnessing first-hand the power of medicine for a family member with cancer. At GSK she contributed to clinical development of over 20 assets, including the second approved personalized therapy for oncology. As she observed market access having an increasing role on product uptake, she transitioned to a role optimizing product strategy for newly launched and mature products at GSK, including supporting the launch of the first gene therapy for a rare disease.
Her consulting roles span US and global clinical, market access, and HEOR evidence strategy for advanced oncolytics, diagnostics, medical devices, and cell and gene therapies. She has developed robust channel, product, and market access strategies for the US market. Moira is passionate about uniting diverse client and consulting teams around the common goal of bringing science and technology to patients who need it.
Moira holds a PhD in chemistry from the University of Michigan and an MBA from the Duke Fuqua School of Business with a certificate in health sector management.
Latest news
Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude
Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows LONDON, U.K, March 10, 2026 Clarivate Plc…
National Research Council of Italy Joins Early Adopter Cohort for Web of Science Research Intelligence
London, U.K. March 9, 2026: Consiglio Nazionale delle Ricerche (CNR), the National Research Council of Italy, has joined the early adopter program for Web of Science Research Intelligence from Clarivate,…
Clarivate Library Innovation Awards Reveal the 2026 Finalists
An independent judging panel selected finalists who demonstrated exceptional creativity, innovation and impact London, U.K. March 5, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced…
